z-logo
Premium
Basis of false‐positive glucagon tests for pheochromocytoma
Author(s) -
Kuchel Otto,
Harnet Pavel,
Buu Nguyen T,
Larochelle Pierre
Publication year - 1981
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1981.96
Subject(s) - pheochromocytoma , glucagon , medicine , hormone
In more than half of 67 patients suspected of having pheochromocytoma, glucagon stimulation increased plasma free norepinephrine (NE) and epinephrine (E) 50% or more, with rising blood pressure or pulse rate; only three patients, however, harbored a pheochromocytoma. A low degree of catecholamine conjugation accounts for most of the false‐positive results. In patients with low conjugated NE + E there was a greater rise in free NE + E and free E as well as in pulse rate after glucagon stimulation than in those with normal levels of conjugated NE + E. Glueagon‐sensuive adenylate cyclase was found in pheochromocytomas but not in afunctional adrenocortical adenomas. After sham administration of glucagon, there were rises in blood pressure but not in free NE or E in four patients. The glucagon‐induced catecholamine test can be false‐positive in hyperadrenergic essential hypertensive patients with abnormally low conjugated NE + E. Saline alone in a sham glucagon test in susceptible patients raises systolic blood pressure and pulse rate, and therefore, if plasma free NE and E are measured and found not to rise this type of false‐positive result can be eliminated. Clinical Pharmacology and Therapeutics (1981) 29, 687–694; doi: 10.1038/clpt.1981.96

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom